Patent & Trade Mark
Attorneys
Brittany Howard
Brittany Howard
Patent Attorney


Level 14, 90 Collins St
Melbourne VIC 3000 AUSTRALIA
Tel +61 3 8618 4157
Fax +61 2 8618 4100
Recent Publications
16 Jan 2017
WIPO has published its World Intellectual Property Indicators 2016 report, which details a healthy growth of intellectual property filings in 2015. Overall, the statistics demonstrate a positive trend in global innovation for the year, with patent filings increasing by 7.8% and trade mark filings increasing by a staggering 15.3%.

15 Jul 2016
The Trans-Pacific Partnership is back in the news, today, with US Senator Orrin Hatch accusing Australia of wanting to steal American patents.

21 Jun 2016
Cultural change is at the core of the new National Innovation and Science Agenda, say its proponents. Australia has a science and innovation problem. By now, most of us are aware of the bleak statistics – Australia is ranked ninth in the Global Innovation Index in respect of the calibre of its science institutions, yet 72nd for innovation efficiency. So why do we continue to have such trouble traversing the gap between scientific research and innovation?

Brittany is a Patent Attorney in our Melbourne Chemistry team with a keen interest in commercialisation strategy and intellectual asset management. She utilises her knowledge in these areas to take a holistic approach to helping manage clients’ intellectual property portfolios.

Brittany has experience handling large patent portfolios for large multinational pharmaceutical and chemical companies including queries, prosecutions, assignments, licenses, amendments, and term extensions. She also provides infringement and validity, freedom to operate, and strategic patenting advice. Brittany is familiar with patent legislation in Australia, New Zealand, the United States, and Europe.

Prior to joining the intellectual property profession, Brittany worked with the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health in Bethesda, Maryland in the United States. While working with the Institute, she conducted research into the design and synthesis of antagonists of G protein-coupled receptors implicated in diabetes and obesity.

Her PhD at the Monash Institute of Pharmaceutical Sciences (MIPS) saw Brittany employ computational chemistry to design inhibitors of Plasmodium falciparum phosphodiesterase enzymes, synthesise these organic compounds in the laboratory, and biologically evaluate the compounds, which have demonstrated potent antimalarial activity. Brittany also worked as a Research Assistant at the Walter and Eliza Hall Institute of Medical Research, researching the synthesis of novel molecules as effective anti-cancer therapies.

Brittany undertakes considerable work in the chemistry industry as a RACI Victorian Committee Member and as a contributor to Chemistry in Australia and a number of IP blogs, journals and magazines.

Education

  • Master of Intellectual Property Law from the University of Melbourne 
  • PhD in Medicinal Chemistry from Monash University
  • Graduate Certificate in Commercialising Research from Monash University
  • Bachelor in Medicinal Chemistry (Honours) from Monash University
Key Areas of Expertise
  • medicinal chemistry
  • pharmaceuticals
  • synthetic organic chemistry
  • inorganic chemistry
  • formulations and compositions
  • material and polymer chemistry
  • clean technology
  • agricultural chemistry
  • simple mechanics
  • dentifrice compositions
  • sanitary and personal hygiene articles
  • 3D printing technology
Industry Focus
Professional Affiliations
  • Regular author for Chemistry in Australia
  • RACI Member and Victorian Committee Member
  • AusBiotech Member
  • American Chemical Society Member